Rob Davis, Merck CEO (Jacquelyn Martin/AP Images)

May 31, 2024 03:53 PM EDT

Merck CEO says Keytruda is ‘not a repeatable model’

Kyle LaHucik

Biotech Correspondent

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

The ‘MAHA report’: Four key takeaways on vaccines, medicine and the pharma industry

Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

FDA adcomm votes unanimously against Pfizer's prostate cancer drug combo

Post-Hoc: AI bio needs to heed the overhyped history of CRISPR

House passes Trump tax bill with PBM and orphan drug reforms included

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?